A strategy to reduce donor-specific HLA Abs before allogeneic transplantation

Bone Marrow Transplant. 2014 May;49(5):722-4. doi: 10.1038/bmt.2014.11. Epub 2014 Feb 17.

Authors

U Gergis¹, S Mayer¹, B Gordon¹, T Mark¹, R Pearse¹, T Shore¹, K Van Besien¹

Affiliation

¹ Division of Hematology and Medical Oncology, New York Presbyterian Hospital/Weill Cornell Medical College, New York, NY, USA.

PMID: 24535131
DOI: 10.1038/bmt.2014.11

No abstract available

Publication types

Letter

MeSH terms

Adult
Desensitization, Immunologic / methods*
Female
HLA Antigens / immunology*
Hematopoietic Stem Cell Transplantation / methods*
Humans
Isoantibodies / immunology
Leukemia, Myeloid, Acute / immunology*
Leukemia, Myeloid, Acute / therapy*
Male
Middle Aged
Myelodysplastic Syndromes / immunology
Myelodysplastic Syndromes / therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
Transplantation, Homologous
Young Adult

Substances

HLA Antigens
Isoantibodies